跳转至内容
Merck
CN
所有图片(3)

主要文件

查看所有文档

NXF-10

Millipore

Natrix® Q 小试装置

别名:

Natrix® Q膜吸附器

登录查看公司和协议定价
所有图片(3)

About This Item

UNSPSC代码:
41115711
eCl@ss:
32011308

ligand

quaternary amine

质量水平

400

描述

Natrix® Q Pilot

产品线

Natrix®

参数

75-375 mL/min flow rate

床高度

0.5 mm

柱床体积

15 mL

基质活性基团

Macroporous polymer

孔径

0.4 μm pore size

容量

3 g binding capacity (BSA)(per device)

分离技术

strong anion exchange

运输

ambient

正在寻找类似产品? 访问 产品对比指南

一般描述

Natrix®(Q)层析膜采用革命性的三维大孔水凝胶结构，提供了高密度的吸附位点和快速传质，其吸附能力超过了树脂填料柱，兼具传统膜吸附剂常见的高流速。性能和速度兼备，搭配一次性、即插即用设计为生物分子纯化提供了低风险、可放大的高效解决方案。

Natrix®(Q)层析膜是一种高生产率强阴离子交换膜，专为生物分子纯化而设计。该独特的Natrix®(Q)层析膜是一种多孔聚丙烯酰胺水凝胶，含有高密度的季铵™(Q)结合基团，这些基团直接聚合在惰性大孔膜支架内。互连的孔隙结构和高官能团密度可实现快流速（几秒的停留时间），并在极高负载下具有出色的通量，同时在各种缓冲条件下保持优异的杂质减少率。Natrix®(Q)层析膜设计可提高任何生物工艺设计的生产率、灵活性、工艺稳健性和经济性。Natrix®(Q) Pilot是中等规模的层析膜装置，用于验证和调整操作参数。可用于小规模的临床和商业化生产。
标称单抗精纯能力：150 g

膜结构：有褶的

每个包装 1 台设备
强阴离子交换层析膜设计，可纯化具有高密度季胺配体的生物分子，可在高负载下实现快流速和高通量，同时保持优异的杂质减少率

特点和优势

Natrix® Q 膜吸附器为用户提供：

  • 高密度季胺结合位点可实现快速传质
  • 即使在快流速下也具有高结合能力
  • 一次性、即插即用设备格式的性能和速度相结合，可实现低风险、可扩展的高效生物分子纯化解决方案。

包装

双袋装

法律信息

NATRIFLO is a trademark of Merck KGaA, Darmstadt, Germany
NATRIX is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品？  

试试我们的产品选型工具.

相关产品

产品编号
说明
价格

NXF-50

Natrix® Q工艺600

NXF-20

Natrix® Q Process 150

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Mochao Zhao et al.
Vaccine, 37(36), 5491-5503 (2018-04-09)
Affinity chromatography is among the most powerful separation techniques, achieving the finest separation with high yields even in the most challenging feed streams. Incorporating affinity chromatography in vaccine purification has long been attempted by researchers to improve unit yield and
Renaud Jacquemart et al.
Computational and structural biotechnology journal, 14, 309-318 (2016-08-30)
The current processing paradigm of large manufacturing facilities dedicated to single product production is no longer an effective approach for best manufacturing practices. Increasing competition for new indications and the launch of biosimilars for the monoclonal antibody market have put
Ying Hou et al.
Biotechnology progress, 31(4), 974-982 (2015-05-29)
Protein A chromatography is widely employed for the capture and purification of monoclonal antibodies (mAbs). Because of the high cost of protein A resins, there is a significant economic driving force to seek new downstream processing strategies. Membrane chromatography has

商品

Robust, load independent viral clearance in monoclonal antibody purification with Natrix® Q chromatography membrane

Membrane adsorbers are a cost-effective, robust, single-use solution for monoclonal antibody polishing

Chromatographic Purification of Plasmid DNA (pDNA) for mRNA, Plasmid-based DNA Vaccines, and Viral Vector Applications

See case study examples of how to optimize chromatographic purification of plasmid DNA for Biopharmaceutical Applications.

Egg-based and Cell-based Influenza Vaccine Manufacturing Methods

Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.

Cost Modeling Vaccine Manufacturing: Estimate Production Costs for mRNA and other Vaccine Modalities

A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.

查看所有结果

相关内容

Viral Vector Vaccine Mfg.

A templated process produces live vector vaccines. Challenges: yield loss, filtration, aggregation, scaling. Collaboration overcomes manufacturing hurdles.

病毒疫苗生产

通过合作进行量身定制的病毒疫苗生产，应对病毒特有的挑战。

Virus-Based Vaccine Manufacturing

Tailored viral vaccine manufacturing addresses virus-specific challenges through collaboration.

Adenovirus Vaccine Manufacturing Process

This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门